A Bioequivalence Study Comparing Two Different Tafamidis Formulations

NCT02217813 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer